Back to results
SuspendedPhase 3

Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial

NCT06671912

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Katmai Oncology Group

Anchorage, Alaska, United States

+730 additional locations

View on ClinicalTrials.gov
Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial — TrialFind